A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT00554385. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Long-term Safety and Tolerability of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): An Open-Label Extension Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in children with ADHD.
Study identification
- NCT ID
- NCT00554385
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 283 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2007 (Type not available)
- Primary completion
- Aug 2008 (Actual)
- Completion
- Not listed
- Last update posted
- Aug 23, 2011
Started 2007
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Ref #/Investigator 6800 | Little Rock | Arkansas | 72205 | — |
| Site Ref #/Investigator 6812 | Boulder | Colorado | 80304 | — |
| Site Ref #/Investigator 8366 | Bradenton | Florida | 34208 | — |
| Site Ref #/Investigator 6808 | Jacksonville | Florida | 32216 | — |
| Site Ref #/Investigator 6827 | Orlando | Florida | 32806 | — |
| Site Ref #/Investigator 8383 | Libertyville | Illinois | 60048 | — |
| Site Ref #/Investigator 6802 | Northbrook | Illinois | 60062 | — |
| Site Ref #/Investigator 6824 | Overland Park | Kansas | 66212 | — |
| Site Ref #/Investigator 8428 | Troy | Michigan | 48085 | — |
| Site Ref #/Investigator 6902 | Omaha | Nebraska | 68198 | — |
| Site Ref #/Investigator 6856 | Las Vegas | Nevada | 89128 | — |
| Site Ref #/Investigator 6683 | Clementon | New Jersey | 08021 | — |
| Site Ref #/Investigator 8297 | Oklahoma City | Oklahoma | 73103 | — |
| Site Ref #/Investigator 6682 | Eugene | Oregon | 97401 | — |
| Site Ref #/Investigator 6811 | Portland | Oregon | 97210 | — |
| Site Ref #/Investigator 8701 | Portland | Oregon | 97210 | — |
| Site Ref #/Investigator 6681 | Salem | Oregon | 97301 | — |
| Site Ref #/Investigator 6799 | Charleston | South Carolina | 29405 | — |
| Site Ref #/Investigator 7955 | Memphis | Tennessee | 38119 | — |
| Site Ref #/Investigator 6836 | Austin | Texas | 78756 | — |
| Site Ref #/Investigator 6835 | Herndon | Virginia | 20170 | — |
| Site Ref #/Investigator 6791 | Bellevue | Washington | 98007 | — |
| Site Ref #/Investigator 6838 | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00554385, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2011 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00554385 live on ClinicalTrials.gov.